# Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

> **NCT00435461** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1000 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** Fluticasone furoate and fexofenadine

## Key facts

- **NCT ID:** NCT00435461
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12-20
- **Primary completion:** 2007-02-01
- **Final completion:** 2007-02-28
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435461, "Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00435461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*